"I am very impressed with the format and content of the journal, articles
are concise, easy to follow and informative" Stanley C Bell, Director of
Discovery Chemistry, Allelix Neuroscience (USA)
Rapid reports from the frontiers of investigational drug research IDrugs
IDrugs - the Investigational Drugs journal - is a monthly review
journal that saves you time and money by bringing you reports from the most
noteworthy and topical meetings happening around the world.
Particular emphasis is placed on the rapid publication of information
disclosed at these scientific meetings, which we bring to you within weeks. In
addition, IDrugs offers you a selection of expert evaluations of investigational
drugs, feature articles highlighting important issues in drug research and analysis taken
from the Investigational Drugs database (IDdb3).
Meetings
Important information on the discovery and development of
drugs is often disclosed at scientific meetings, particularly in oral
presentations, long before publication in the primary literature.
IDrugs provides unparalleled coverage of scientific meetings through its
network of scientific reporters, who attend meetings in their fields of
expertise, and are thus able to provide their expert opinion on the
presentations and data disclosed.
Thomson Scientific commissions reports from over 300 scientific meetings each
year, and the best of these are published in IDrugs, within weeks of the
event.
Features
Expert viewpoints on hot topics from within the pharmaceutical, technology,
regulatory and financial industries, and academia are provided.
Features offer a forum for discussion of important issues or controversy in
the drug R&D community. The articles are presented in an informative and
thought-provoking style, and are written with qualified but non-specialist researchers
in mind.
Drug
evaluationsExpert commentary on the scientific and commercial potential
of selected drugs in clinical trials are provided in each issue of IDrugs.
Thomson Scientific systematically collects published references to investigational
drugs and commissions scientific experts to review the information, thus
providing a guide to the literature. IDrugs publishes a selection of drug
evaluations in each issue, based on the strength of the commercial or scientific
interest in the drug concerned.
IDrugs is an invaluable publication for
anyone with an interest in investigational drugs.